INT273620

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.48
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
muscle 4
GUCY2C (Homo sapiens)
Pain Link Frequency Relevance Heat
fibrosis 2 27.68 Quite Low
withdrawal 2 22.32 Low Low
antagonist 34 5.00 Very Low Very Low Very Low
Calcium channel 14 5.00 Very Low Very Low Very Low
agonist 12 5.00 Very Low Very Low Very Low
Serotonin 10 5.00 Very Low Very Low Very Low
Pain 6 5.00 Very Low Very Low Very Low
tolerance 6 5.00 Very Low Very Low Very Low
sSRI 4 5.00 Very Low Very Low Very Low
headache 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pulmonary Hypertension 212 98.90 Very High Very High Very High
Hypoxia 6 76.20 Quite High
Cv General 4 Under Development 18 57.00 Quite High
Syncope 6 56.16 Quite High
Acute Disease 2 54.84 Quite High
Increased Venous Pressure Under Development 34 33.20 Quite Low
Bronchopulmonary Dysplasia 2 29.20 Quite Low
Asthma 2 28.00 Quite Low
Cystic Fibrosis 2 27.68 Quite Low
Airway Obstruction 4 25.08 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Nitric oxide (NO) inhalation is currently among the first line treatments for post-operative pediatric pulmonary hypertension or in the child with acute severe new presentation of PAH being managed on the intensive care unit,36,37 as it reduces PA pressure rapidly.38 Inhaled NO therapy is also used acutely in persistent pulmonary hypertension of the newborn.39 The mode of action of NO is via the stimulation of guanylyl cyclase and hence increased production of cyclic guanylate monophosphate (cGMP) in pulmonary smooth muscle cells; this causes uptake of calcium into the sarcoplasmic reticulum, which then leads to muscle relaxation, reduced PA pressure and PVR, and hence increased oxygenation.
Positive_regulation (increased) of Gene_expression (production) of guanylyl cyclase in muscle associated with pulmonary hypertension
1) Confidence 0.01 Published 2009 Journal Vascular Health and Risk Management Section Body Doc Link PMC2697585 Disease Relevance 0.74 Pain Relevance 0
Nitric oxide (NO) inhalation is currently among the first line treatments for post-operative pediatric pulmonary hypertension or in the child with acute severe new presentation of PAH being managed on the intensive care unit,36,37 as it reduces PA pressure rapidly.38 Inhaled NO therapy is also used acutely in persistent pulmonary hypertension of the newborn.39 The mode of action of NO is via the stimulation of guanylyl cyclase and hence increased production of cyclic guanylate monophosphate (cGMP) in pulmonary smooth muscle cells; this causes uptake of calcium into the sarcoplasmic reticulum, which then leads to muscle relaxation, reduced PA pressure and PVR, and hence increased oxygenation.
Positive_regulation (stimulation) of Gene_expression (production) of guanylyl cyclase in muscle associated with pulmonary hypertension
2) Confidence 0.01 Published 2009 Journal Vascular Health and Risk Management Section Body Doc Link PMC2697585 Disease Relevance 0.74 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox